FDA Drug Recalls

Recalls / Class II

Class IID-0426-2025

Product

KOFAL, Athletes, Penetrating Pain Relief, External Analgesic Ointment (methyl salicylate 10.5% - External Analgesic), 2 oz (60 g) Jar, Distributed by: Pharmadel LLC, New Castle, DE 19720, NDC 55758-109-02, UPC 8 99711 00101 3.

Brand name
Kofal
Generic name
Methyl Salicylate
Active ingredient
Methyl Salicylate
Route
Topical
NDC
55758-109
FDA application
M017
Affected lot / code info
Lot SP30A, Exp Date: 09/30/2026

Why it was recalled

CGMP Deviations

Recalling firm

Firm
KENIL HEALTHCARE PRIVATE LIMITED
Manufacturer
Pharmadel LLC
Notification channel
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Type
Voluntary: Firm initiated
Address
Plot 319, Village Acharasan, Ankhol-Vamaj Road, Ta. Kadi, District Mehsana, N/A N/A, India

Distribution

Quantity
11,808 Jars
Distribution pattern
DE and NC

Timeline

Recall initiated
2025-04-24
FDA classified
2025-05-19
Posted by FDA
2025-05-28
Terminated
2026-02-19
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0426-2025. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: Kofal · FDA Drug Recalls